Share Name Share Symbol Market Type Share ISIN Share Description
Scapa Group Plc LSE:SCPA London Ordinary Share GB0007281198 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 231.00 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
231.00 232.50 0.00 0.00 0.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 311.80 14.90 5.30 43.6 359
Last Trade Time Trade Type Trade Size Trade Price Currency
17:54:37 O 21 231.00 GBX

Scapa (SCPA) Latest News

More Scapa News
Scapa Takeover Rumours

Scapa (SCPA) Discussions and Chat

Scapa Forums and Chat

Date Time Title Posts
29/11/201916:15Scapa onwards and upwards1,469
05/10/200614:18Scapa.......nobrainer or should I scarper?76
16/3/200613:43SCAPA upwards147

Add a New Thread

Scapa (SCPA) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
07:17:53231.002148.51O
07:17:53231.873,0046,965.46O
07:17:53231.0010,09823,326.38O
07:17:53231.001,1642,688.84O
07:17:53231.602,7236,306.58O
View all Scapa trades in real-time

Scapa (SCPA) Top Chat Posts

DateSubject
11/12/2019
08:20
Scapa Daily Update: Scapa Group Plc is listed in the Chemicals sector of the London Stock Exchange with ticker SCPA. The last closing price for Scapa was 231p.
Scapa Group Plc has a 4 week average price of 216p and a 12 week average price of 192.20p.
The 1 year high share price is 404p while the 1 year low share price is currently 145p.
There are currently 155,242,923 shares in issue and the average daily traded volume is 433,455 shares. The market capitalisation of Scapa Group Plc is £358,611,152.13.
19/11/2019
14:13
marmar80: Looks like the loss of Convatec business didn't do as much damage as the share price is showing. Was down from 400 to below 200 on that announcement back in the days. Now we know that Scapa is demanding 83m+ from Convatec and officially Convatec's contra claim is rejected. Revenue up. Loss was made but promise of more to come from other businesses. For me it's a very solid update and can lead to an nice pay out in case of win against Convatec.
17/10/2019
12:00
woodhawk: On the back of the recent strong results and with the potential of damages from Convatec, the share price really ought to be heading strongly north, back towards 300p.
09/10/2019
07:13
marmar80: When they announced contract loss the share price tanked by 50% and still is almost 40% down.
26/7/2019
10:36
mallorca 9: (Sharecast News) - Analysts at Berenberg slashed their target price on diversified healthcare and industrial company Scapa on Tuesday, but said the group's "positive start" to the year should restore some investor confidence. Berenberg cut its price target on the group from 520p to 300p but said that Scapa's first-quarter figures, released earlier in the day, showed that things were "not all doom and gloom" for the business, which revealed organic growth in both divisions. The bank said Scapa's first-quarter trading update was "solid", with revenues increasing 34.6% on a continuing FX basis. Berenberg noted that even when excluding Scapa's recent contract wins with ConvaTec and Systagenix, the group still delivered 3% organic growth in its industrial business and 4% in its healthcare division. "In the context of the current share price fall, we think this is a good result," said the German bank. "With positive trading and Scapa clearly confident enough about its case versus CVT (it recently decided to pursue legal action), we feel that the risk is skewed to the upside." However, Berenberg did opt to adjust its numbers to reflect lost ConvaTec revenues of £27m and underlying earnings of £13m, bringing it in line with consensus. While Berenberg lowered its price target on the company, the analysts said they still believe in Scapa's long-term story and confidently reiterated their 'buy' rating on the stock. As of 1310 BST, Scapa shares had picked up 1.45% to 168p.
23/7/2019
08:06
aztec786: Scapa share price seems to be doin well. P/E ratio of 8 makes this a serious bargain. Thx Mallorca
19/7/2019
15:46
hopefuldave: Worry!!cant get used to losing money. This is quite a drop but I am now focusing on the quality of scapa, and a return to a higher share price soon I hope.
19/7/2019
09:09
mallorca 9: Normally I'd be wary of 'catching a falling knife' however Directors buying solid report just issued dividend increased by 20% new plant opened in India 8% sales growth in Asia Completed acquisition Just can't see anything but an eventual recovery in the share price here.
18/7/2019
17:50
woodhawk: "Do you seriously think scapa will come back from this continuous fall in its share price? If yes, based on what?" 1) Yes 2) Long experience of being a contrarian. That enough for you HopelessDave? One day you'll learn that you have to think ahead in this game and not follow the herd.
16/7/2019
16:51
kazoom: Fair enough Woody - just my view that the litigation could go either way and the share price is probably in the middle of the two outcomes; so I don't think the bad new is all in the price in this case - lose the case and further down imho. Anyway good luck with it. I'll sit and watch for now.
14/6/2019
07:31
robow: from The Daily Telegraph Questor: money flows out of Scapa but readers should resist any temptation to join the flood Questor Inheritance Tax Portfolio: after a torrid month for the tapes maker – the loss of its boss and a big contract – things are now looking more rosy It’s been an eventful few weeks for Scapa, the maker of industrial and medical tapes tipped here in March last year at 471.4p. On May 21 it published perfectly satisfactory full-year results but unnerved the market somewhat by announcing that its chief executive, Heejae Chae, who had largely steered the company’s successful restructuring, was stepping down. Two weeks later came a much bigger bombshell: Scapa said it had received notice from a large customer, ConvaTec, that it was terminating a contract in North America worth about $30m (£24m) a year in sales. The shares lost 47pc. Then on Monday this week the company said Mr Chae had agreed to rescind his resignation and would stay on “to execute the current strategy” Keith Ashworth-Lord, who holds Scapa in his SDL UK Buffettology fund, told Questor: “The results in May were nothing other than good, but Chae’s retirement was a bolt from the blue. He is regarded as the architect of the firm in its present form and the market thought there were no succession plans. “Then, when the ConvaTec announcement came, investors put two and two together, came up with five and crucified the share price.” He added: “Last week a group of shareholders, including us, tried to get him to change his mind and convince the market that he hadn’t resigned over ConvaTec. We got the result we wanted this week and the shares have recovered to about 195p.” He said the loss of the contract was “material but not the roof falling in”. “Chae will stay until the problems are solved and that will give Scapa time to sort out the succession,” he added. “This holding has not been my finest but we are sticking with it. We bought more shares heavily after the fall – about 800,000 at various prices as low as 159p. We think it’s been an absolutely classic overreaction by the market. Personally I’m very relaxed about the whole thing.” Questor: hold Ticker: SCPA Share price at close: 199p
Scapa share price data is direct from the London Stock Exchange
Your Recent History
LSE
SCPA
Scapa
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191212 08:10:54